Key facts
- It has raised $42.5M; the latest was Later Stage VC ($20.0M) in Mar 2025.
- Notable investors include SparkLabs Group, Cherubic Ventures, WI Harper Group, Verge Capital Management, Alibaba Entrepreneurs Fund — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Health2Sync
- ·The full record, as it builds
Funding rounds
No funding rounds for Health2Sync are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Health2Sync
Provider of a mobile application designed to simplify and personalize diabetes management. The company's application allows patients to track vitals such as blood glucose levels, blood pressure, and weight, along with factors that influence those readings such as diet, exercise and medication as well as offers analysis, reminders, and educational content, enabling diabetics to better self-manage their blood glucose and allow family and health professionals to provide care where necessary.
- Sector
- Healthcare
- HQ
- Taipei, Taiwan
- Founded
- 2013
- Employees
- 90
- Website
- health2sync.com/
- Ownership
- Privately Held (backing)
Health2Sync doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Health2Sync shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Health2Sync in its N-PORT filings yet. We sweep new filings monthly.